Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Blix ES"'
Autor:
Ohnstad HO; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo., Blix ES; Department of Oncology, University of North Norway, Tromsø; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø., Akslen LA; Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, Section for Pathology, University of Bergen, Bergen; Department of Pathology Haukeland University Hospital, Bergen., Gilje B; Department of Haematology and Oncology, Stavanger University Hospital, Stavanger., Raj SX; Department of Oncology, St Olavs Hospital, Trondheim., Skjerven H; Department of Breast Surgery, Vestre Viken Hospital Trust, Drammen., Borgen E; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo., Janssen EAM; Department of Pathology, Stavanger University Hospital, Stavanger; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Stavanger, Norway; Menzies Health Institute Queensland and Griffith University, Southport, Australia., Mortensen E; Department of Pathology, University of North Norway, Tromsø., Brekke MB; Department of Pathology, St Olavs Hospital, Trondheim., Falk RS; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo., Schlichting E; Department of Oncology, Breast and Endocrine Surgery Unit, Division of Cancer Medicine, Oslo University Hospital, Oslo., Boge B; Department of Oncology, Hospital of Southern Norway, Kristiansand., Songe-Møller S; Department of Oncology, Østfold Hospital Trust, Kalnes., Olsson P; Department of Breast Surgery, Innlandet Hospital Trust, Hamar., Heie A; Department of Breast Surgery, Haukeland University Hospital, Bergen., Mannsåker B; Department of Oncology, Nordland Hospital, Bodø., Vestlid MA; Department of Breast Surgery, Telemark Hospital Trust, Skien., Kursetgjerde T; Department of Oncology, Møre og Romsdal Hospital Trust, Ålesund., Gravdehaug B; Department of Breast Surgery, Akershus University Hospital, Lørenskog., Suhrke P; Department of Pathology, Vestfold Hospital Trust, Tønsberg., Sanchez E; Department of Oncology, Haugesund Hospital, Haugesund., Bublevic J; Department of Oncology, Førde Central Hospital, Førde., Røe OD; Department of Oncology, Levanger Hospital, Levanger., Geitvik GA; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo., Halset EH; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo., Rypdal MC; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo., Langerød A; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo., Lømo J; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo., Garred Ø; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo., Porojnicu A; Department of Oncology, Vestre Viken Hospital Trust, Drammen., Engebraaten O; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo; Institute of Clinical Medicine, University of Oslo, Oslo., Geisler J; Institute of Clinical Medicine, University of Oslo, Oslo; Department of Oncology, Akershus University Hospital, Lørenskog., Lyngra M; Department of Pathology, Akershus University Hospital, Lørenskog., Hansen MH; Department of Breast Surgery, University of North Norway, Tromsø., Søiland H; Department of Research, Stavanger University Hospital, Stavanger; Department of Clinical Science, University of Bergen, Bergen., Nakken T; User representative, Oslo University Hospital, Oslo., Asphaug L; Clinical Trials Unit, Oslo University Hospital, Oslo; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo., Kristensen V; Institute of Clinical Medicine, University of Oslo, Oslo., Sørlie T; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo; Institute of Clinical Medicine, University of Oslo, Oslo., Nygård JF; Cancer Registry of Norway, Oslo., Kiserud CE; National Advisory Unit for Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway., Reinertsen KV; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo; National Advisory Unit for Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway., Russnes HG; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo; Institute of Clinical Medicine, University of Oslo, Oslo., Naume B; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo; Institute of Clinical Medicine, University of Oslo, Oslo. Electronic address: BNa@ous-hf.no.
Publikováno v:
ESMO open [ESMO Open] 2024 Jun; Vol. 9 (6), pp. 103475. Date of Electronic Publication: 2024 Jun 04.
Autor:
Helland Å, Steinskog ESS, Blix ES, Flobak Å, Brabrand S, Puco K, Niehusmann P, Meltzer S, Oppedal IA, Haug Å, Torkildsen CF, Randen U, Gilje B, Lønning PE, Gjertsen BT, Hovland R, Russnes HG, Fagereng GL, Smeland S, Tasken K
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2024 Jan 18; Vol. 144 (1). Date of Electronic Publication: 2024 Jan 18 (Print Publication: 2024).
Autor:
Nikolaienko O; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Eikesdal HP; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Ognedal E; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Gilje B; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Lundgren S; Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Blix ES; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Espelid H; Department of Surgery, Haugesund Hospital, Haugesund, Norway., Geisler J; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Geisler S; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Janssen EAM; Department of Pathology, Stavanger University Hospital, Stavanger, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Stavanger, Norway., Yndestad S; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Minsaas L; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Leirvaag B; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Lillestøl R; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Knappskog S; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Lønning PE; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway. per.lonning@helse-bergen.no.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway. per.lonning@helse-bergen.no.
Publikováno v:
Genome medicine [Genome Med] 2023 Dec 06; Vol. 15 (1), pp. 104. Date of Electronic Publication: 2023 Dec 06.
Autor:
Yndestad S; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Engebrethsen C; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Herencia-Ropero A; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Nikolaienko O; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Vintermyr OK; Department of Pathology, Haukeland University Hospital, Bergen, Norway.; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway., Lillestøl RK; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Minsaas L; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Leirvaag B; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Iversen GT; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Gilje B; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Blix ES; Immunology Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Espelid H; Department of Surgery, Haugesund Hospital, Haugesund, Norway., Lundgren S; Cancer Clinic, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Geisler J; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Aase HS; Department of Radiology, Haukeland University Hospital, Bergen, Norway., Aas T; Department of Surgery, Haukeland University Hospital, Bergen, Norway., Gudlaugsson EG; Department of Pathology, Stavanger University Hospital, Stavanger, Norway., Llop-Guevara A; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Serra V; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Janssen EAM; Department of Pathology, Stavanger University Hospital, Stavanger, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Stavanger, Norway., Lønning PE; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Knappskog S; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Eikesdal HP; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Deceased.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2023 Sep; Vol. 7, pp. e2300338.
Autor:
Taskén K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Kjetil.tasken@medisin.uio.no.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Kjetil.tasken@medisin.uio.no., Russnes HEG; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Aas E; Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway.; Division of Health Services, Norwegian Institute of Public Health, Oslo, Norway., Bjørge L; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.; Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Blix ES; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.; Institute of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway., Enerly E; Department of Research, Cancer Registry of Norway, Oslo, Norway., Fagereng GL; Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Flobak Å; The Cancer Clinic, St. Olav University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Gilje B; Department of Oncology, Stavanger University Hospital, Stavanger, Norway., Gjertsen BT; Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway.; Haematology Section, Department of Medicine, Haukeland University Hospital, Bergen, Norway., Guren TK; Department of Oncology, Oslo University Hospital, Oslo, Norway., Heix J; CONNECT Public-Private Partnership, Oslo Cancer Cluster SA, Oslo, Norway., Hovig E; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway., Hovland R; Section for Cancer Genomics, Haukeland University Hospital, Bergen, Norway., Lønning PE; Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Meza-Zepeda LA; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Core Facilities, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Mæhle PM; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Nilsen HL; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Clinical Molecular Biology, Akershus University Hospital, Lørenskog, Norway., Thoresen SØ; CONNECT Public-Private Partnership, Oslo Cancer Cluster SA, Oslo, Norway.; Merck AB NUF, Oslo, Norway., Widerberg K; CONNECT Public-Private Partnership, Oslo Cancer Cluster SA, Oslo, Norway., Smeland S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Helland Å; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Nature medicine [Nat Med] 2022 May; Vol. 28 (5), pp. 885-887.
Autor:
Mecinaj A; Department of Cardiology, Division of Medicine, Akershus University Hospital, Sykehusveien 25, 1478, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Gulati G; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Division of Research and Innovation, Akershus University Hospital, Lørenskog, Norway., Heck SL; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Diagnostic Imaging, Akershus University Hospital, Lørenskog, Norway., Holte E; Clinic of Cardiology, St. Olavs Hospital, Trondheim, Norway.; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology NTNU, Trondheim, Norway., Fagerland MW; Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway., Larsen AI; Department of Cardiology, Stavanger University Hospital, Stavanger, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Blix ES; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.; Immunology Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway., Geisler J; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway., Wethal T; Department of Stroke, Clinic of Medicine, St. Olavs Hospital, Trondheim, Norway.; Department of Neuromedicine and Movement Science, NTNU, Trondheim, Norway., Omland T; Department of Cardiology, Division of Medicine, Akershus University Hospital, Sykehusveien 25, 1478, Lørenskog, Norway. torbjorn.omland@medisin.uio.no.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. torbjorn.omland@medisin.uio.no.
Publikováno v:
Cardio-oncology (London, England) [Cardiooncology] 2021 Sep 27; Vol. 7 (1), pp. 33. Date of Electronic Publication: 2021 Sep 27.
Autor:
Helland T; Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Norway., Naume B; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway., Hustad S; Core Facility for Metabolomics, Department of Clinical Science, University of Bergen, Norway., Bifulco E; Core Facility for Metabolomics, Department of Clinical Science, University of Bergen, Norway., Kvaløy JT; Department of Mathematics and Physics, University of Stavanger, Norway.; Department of Research, Stavanger University Hospital, Norway., Saetersdal AB; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Norway., Synnestvedt M; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Norway., Lende TH; Department of Surgery, Section for Breast and Endocrine Surgery, Stavanger University Hospital, Norway., Gilje B; Department of Oncology and Radiotherapy, Stavanger University Hospital, Norway., Mjaaland I; Department of Oncology and Radiotherapy, Stavanger University Hospital, Norway., Weyde K; Department of Oncology, Sykehuset Innlandet, Gjøvik, Norway., Blix ES; Immunology Research Group, Institute of Medical Biology, University of Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Wiedswang G; Department of GI-Surgery, Oslo University Hospital, Norway., Borgen E; Department of Pathology, Oslo University Hospital, Norway., Hertz DL; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI, USA., Janssen EAM; Department of Pathology, Stavanger University Hospital, Norway.; Department of Bioscience and Environmental Engineering, University of Stavanger, Norway., Mellgren G; Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Norway., Søiland H; Department of Clinical Science, University of Bergen, Norway.; Department of Oncology and Radiotherapy, Stavanger University Hospital, Norway.
Publikováno v:
Molecular oncology [Mol Oncol] 2021 Apr; Vol. 15 (4), pp. 957-967. Date of Electronic Publication: 2020 Dec 14.
Autor:
Eikesdal HP; Department of Oncology, Haukeland University Hospital, Bergen, Norway; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway. Electronic address: hans.eikesdal@uib.no., Yndestad S; Department of Oncology, Haukeland University Hospital, Bergen, Norway; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Elzawahry A; Department of Oncology, Haukeland University Hospital, Bergen, Norway; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Llop-Guevara A; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Gilje B; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Blix ES; Immunology Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Espelid H; Department of Surgery, Haugesund Hospital, Haugesund, Norway., Lundgren S; Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Geisler J; Department of Oncology, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Vagstad G; Department of Oncology, Førde Hospital, Førde, Norway., Venizelos A; Department of Oncology, Haukeland University Hospital, Bergen, Norway; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Minsaas L; Department of Oncology, Haukeland University Hospital, Bergen, Norway; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Leirvaag B; Department of Oncology, Haukeland University Hospital, Bergen, Norway; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Gudlaugsson EG; Department of Pathology, Stavanger University Hospital, Stavanger, Norway., Vintermyr OK; Department of Pathology, Haukeland University Hospital, Bergen, Norway; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway., Aase HS; Department of Radiology, Haukeland University Hospital, Bergen, Norway., Aas T; Department of Surgery, Haukeland University Hospital, Bergen, Norway., Balmaña J; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Serra V; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Janssen EAM; Department of Pathology, Stavanger University Hospital, Stavanger, Norway., Knappskog S; Department of Oncology, Haukeland University Hospital, Bergen, Norway; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Lønning PE; Department of Oncology, Haukeland University Hospital, Bergen, Norway; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Feb; Vol. 32 (2), pp. 240-249. Date of Electronic Publication: 2020 Nov 24.
Autor:
Hald SM; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromso, Norway. Electronic address: sigurd.hald@uit.no., Rakaee M; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromso, Norway., Martinez I; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromso, Norway., Richardsen E; Department of Clinical Pathology, University Hospital of North Norway, Tromso, Norway; Department of Medical Biology, UiT The Arctic University of Norway, Tromso, Norway., Al-Saad S; Department of Clinical Pathology, University Hospital of North Norway, Tromso, Norway; Department of Medical Biology, UiT The Arctic University of Norway, Tromso, Norway., Paulsen EE; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromso, Norway; Department of Oncology, University Hospital of North Norway, Tromso, Norway., Blix ES; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromso, Norway; Department of Oncology, University Hospital of North Norway, Tromso, Norway., Kilvaer T; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromso, Norway; Department of Oncology, University Hospital of North Norway, Tromso, Norway., Andersen S; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromso, Norway; Department of Oncology, University Hospital of North Norway, Tromso, Norway., Busund LT; Department of Clinical Pathology, University Hospital of North Norway, Tromso, Norway; Department of Medical Biology, UiT The Arctic University of Norway, Tromso, Norway., Bremnes RM; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromso, Norway; Department of Oncology, University Hospital of North Norway, Tromso, Norway., Donnem T; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromso, Norway; Department of Oncology, University Hospital of North Norway, Tromso, Norway.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2018 May; Vol. 19 (3), pp. 249-259.e2. Date of Electronic Publication: 2017 Dec 11.
Autor:
Francolini G; Department of Oncology, Aarhus University Hospital, Denmark; Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Italy., Thomsen MS; Department of Medical Physics, Aarhus University Hospital, Denmark., Yates ES; Department of Medical Physics, Aarhus University Hospital, Denmark., Kirkove C; Department of Radiation Oncology, Catholic University of Louvain, Belgium., Jensen I; Department of Medical Physics, Aalborg University Hospital, Denmark., Blix ES; Department of Oncology, University Hospital of North Norway, Norway; Immunology Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway., Kamby C; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Nielsen MH; Department of Oncology, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark., Krause M; German Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ) Heidelberg, Department of Radiation Oncology and OncoRay, University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Germany., Berg M; Department of Medical Physics, Hospital of Vejle, Denmark., Mjaaland I; Department of Oncology, Stavanger University Hospital, Norway., Schreiber A; Praxis für Strahlentherapie, Dresden, Germany., Kasti UM; Department of Oncology, Sørlandet Sykehus HF, Kristiansand, Norway., Boye K; Department of Oncology, Zealand University Hospital, Denmark., Offersen BV; Department of Oncology, Aarhus University Hospital, Denmark. Electronic address: birgoffe@rm.dk.
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2017 May; Vol. 123 (2), pp. 282-287. Date of Electronic Publication: 2017 Mar 25.